Showing results (1-10 of 13) with videos related to
Sort By:
Pageof 2
Current Radiopharmaceuticals|November 3, 2023
Design of a New <sup>99m</sup>Tc-radiolabeled Cyclo-peptide as Promising Molecular Imaging Agent of CXCR<sub>4</sub> Receptor: Molecular Docking, Synthesis, Radiolabeling, and Biological EvaluationLeila Hassanzadeh, Mostafa Erfani, Safura Jokar, et al.Biophysical Reviews|November 13, 2019
Recent advances in the design and applications of amyloid-β peptide aggregation inhibitors for Alzheimer's disease therapySafura Jokar, Saeedeh Khazaei, Hossein Behnammanesh, et al.Clinical Nuclear Medicine|July 18, 2024
Recent Clinical Implications of FAPI: Imaging and TherapyMahshid Kiani, Safura Jokar, Leila Hassanzadeh, et al.Iranian Journal of Pharmaceutical Research : IJPR|August 7, 2024
RadioLabeling of the Mutant form of Anti-PlGF Nanobody by <sup>99m</sup>Tc-TricarbonylTahereh Rezazadeh, Akram Sadat Tabatabaee Bafroee, Soraya Shahhosseini, et al.Cellular and Molecular Neurobiology|November 22, 2020
Targeting Caveolin-1 and Claudin-5 with AY9944, Improve Blood-Brain Barrier Permeability; Computational Simulation and Experimental StudyLeila Gholami, Safura Jokar, Yousef Fatahi, et al.Bioorganic Chemistry|July 15, 2020
Design of peptide-based inhibitor agent against amyloid-β aggregation: Molecular docking, synthesis and in vitro evaluationSafura Jokar, Mostafa Erfani, Omid Bavi, et al.Bioengineering (Basel, Switzerland)|June 23, 2022
The Footprint of Exosomes in the Radiation-Induced Bystander EffectsSafura Jokar, Inês A Marques, Saeedeh Khazaei, et al.Journal of Labelled Compounds & Radiopharmaceuticals|August 7, 2025
<sup>99m</sup>Tc-SNW-1 Nanoparticle Labeling and Its Biodistribution/Pathological EvaluationsSetareh Derakhshan, Mehdi Shafiee Ardestani, Tahereh Zadeh Mehrizi, et al.Asia Oceania Journal of Nuclear Medicine & Biology|July 28, 2020
Preclinical study of a new <sup>177</sup>Lu-labeled somatostatin receptor antagonist in HT-29 human colorectal cancer cellsHossein Behnammanesh, Mostafa Erfani, Maliheh Hajiramezanali, et al.Bioorganic Chemistry|October 31, 2019
Design, preparation and biological evaluation of a <sup>177</sup>Lu-labeled somatostatin receptor antagonist for targeted therapy of neuroendocrine tumorsHossein Behnammanesh, Safura Jokar, Mostafa Erfani, et al.Pageof 2